Ariad Pharmaceuticals

Takeda touts positive first-line leukemia results — but isn't quite ready to reveal the hard data
Endpoints
Thu, 11/17/22 - 11:36 pm
Takeda
Ariad Pharmaceuticals
Iclusig
clinical trials
acute lymphoblastic leukemia
OrbiMed-incubated Theseus unveils $100M to beat cancer drug resistance
MedCity News
Sun, 04/18/21 - 11:38 pm
OrbiMed
Ariad Pharmaceuticals
Theseus Pharmaceuticals
cancer
'Burner' phones and Ariad secrets: Goldman Sachs banker pleads guilty for his role in global insider trading ring
Endpoints
Tue, 01/7/20 - 11:14 pm
insider trading
Goldman Sachs
Ariad Pharmaceuticals
Drug Approvals for the 2 Most Common Types of Cancer in the Last 2 Years
BioSpace
Mon, 11/19/18 - 11:29 am
cancer
breast cancer
lung cancer
drug approvals
AstraZeneca
Takeda
Ariad Pharmaceuticals
Merck
Pfizer
Novartis
Boehringer Ingelheim
Bristol-Myers Squibb
Eli Lilly
Puma Biotechnology
Mylan
Genentech
Why Has 2017 Been a Horrible Year So Far for Biotech Acquisitions?
Motley Fool
Mon, 08/14/17 - 10:03 am
biotech
M&A
JNJ
Actelion
Takeda
Ariad Pharmaceuticals
Gilead Sciences
Pfizer
Amgen
Takeda's Ariad deal pays off with blockbuster green light for Alunbrig
Fierce Pharma
Sat, 04/29/17 - 10:04 am
Takeda
Ariad Pharmaceuticals
Alunbrig
ALK-positive non-small cell lung cancer
About that pharma M&A comeback? Sorry. 2017's not bringing it—at least not yet
Fierce Pharma
Mon, 04/10/17 - 10:19 am
M&A
Stada
Shire
Baxalta
JNJ
Actelion
Mylan Labs
Pfizer
Takeda
Ariad Pharmaceuticals
Medivation
Takeda chops into Ariad staff, handing out about 180 pink slips as it revamps Boston ops
Endpoints
Thu, 03/30/17 - 06:33 pm
Takeda
layoffs
Ariad Pharmaceuticals
reorganization
How Takeda won a $5.2B bidding war — against itself
Endpoints
Fri, 01/20/17 - 12:24 pm
Takeda
M&A
Ariad Pharmaceuticals
Takeda deal results in a huge windfall for former Ariad CEO Harvey Berger
Bizjournals.com
Tue, 01/10/17 - 09:12 am
Takeda
Ariad Pharmaceuticals
Harvey Berger
Takeda Pharmaceutical to buy Ariad in $5.2 billion cash deal
Yahoo/AP
Mon, 01/9/17 - 10:13 am
Takeda
Ariad Pharmaceuticals
M&A
3 Big Advances In Cancer Treatment In 2016
Motley Fool
Mon, 12/12/16 - 09:24 am
cancer
Merck
Keytruda
Kite Pharma
KTE-C19
Ariad Pharmaceuticals
brigatinib
Bernie Sanders Follows ‘Greed’ Tweet on Ariad With Letter
Bloomberg
Fri, 10/21/16 - 09:55 am
Bernie Sanders
twitter
Ariad Pharmaceuticals
Iclusig
drug pricing
3 Cancer Drugs That Could Get an FDA OK Next Year
Motley Fool
Mon, 10/10/16 - 09:02 am
FDA
rucaparib
Clovis Oncology
ovarian cancer
binimetinib
Array Biopharma
melanoma
brigatinib
Ariad Pharmaceuticals
non-small cell lung cancer
Ariad Shares Rise Amid Speculation of Potential Buyout
Bloomberg
Tue, 09/20/16 - 08:59 pm
Ariad Pharmaceuticals
M&A
Ariad Taking The Fast Track Into Lung Cancer Treatment
Seeking Alpha
Mon, 06/20/16 - 10:14 am
Ariad Pharmaceuticals
fast track
non-small cell lung cancer
Ponatinib
Here are 13 MA cancer biotechs hoping to make waves next month
Bizjournals.com
Fri, 05/20/16 - 11:36 am
Boston
biotech
ASCO 2016
Ariad Pharmaceuticals
Immunogen
Ziopharm
Vertex Pharmaceuticals
Tokai
Infinity Pharmaceuticals
Momenta
Merrimack
Tesaro
Syndax
Kyropharm
Foundation Medicine
Cerulean Pharma
Ariad Pharmaceuticals Takes An Axe To Its Expenses
Motley Fool
Wed, 03/30/16 - 10:11 am
Ariad Pharmaceuticals
layoffs
Ariad Pharmaceuticals reports fourth-quarter loss, misses expectations
Yahoo/AP
Tue, 02/23/16 - 09:47 am
Ariad Pharmaceuticals
earnings
Why Ariad Pharmaceuticals Flew in August (Hint: It Wasn't Because of Red Bull)
Motley Fool
Tue, 09/8/15 - 08:01 am
Ariad Pharmaceuticals
Baxalta
M&A

Pages